262
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Effect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus

, , , , , & show all
Pages 897-903 | Published online: 08 May 2017

References

  • International Diabetes FederationIDF diabetes atlas 7th edition2014 Available from: http://www.idf.org/diabetesatlas/5e/Update2014Accessed December 28, 2016
  • HeplerCDStrandLMOpportunities and responsibilities in pharmaceutical careAm J Hosp Pharm19904735335432316538
  • GarçãoJACabritaJEvaluation of a pharmaceutical care program for hypertensive patients in rural PortugalJ Am Pharm Assoc (Wash)200242685886412482009
  • González-MartinGJooISánchezIEvaluation of the impact of a pharmaceutical care program in children with asthmaPatient Educ Couns2003491131812527148
  • PaulósCPNygrenCECeledónCCárcamoCAImpact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemiaAnn Pharmacother200539593994315827075
  • SadikAYousifMMcElnayJCPharmaceutical care of patients with heart failureBr J Clin Pharmacol200560218319316042672
  • ClarkPMKaragozTApikoglu-RabusSIzzettinFVEffect of pharmacist-led patient education on adherence to tuberculosis treatmentAm J Health Syst Pharm200764549750517322163
  • Al MazrouiNRKamalMMGhabashNMYacoutTAKolePLMcElnayJCInfluence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitusBr J Clin Pharmacol200967554755719552750
  • ChungNRascatiKLopezDJokerstJGarzaAImpact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved populationJ Manag Care Spec Pharm201420991491925166290
  • Obreli-NetoPRMarusicSGuidoniCMEconomic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary health care: a 36-month randomized controlled clinical trialJ Manag Care Spec Pharm2015211667525562774
  • WeiLNJingFBLiuYFWandKWangYLDiscussion on the model of patient education and pharmaceutical care on a hypertension patient by clinical pharmacistsChina Licensed Pharmacists2013922
  • QianNPWeiRXPharmaceutical care for drug treatment provided by clinical pharmacists in Oncology DepartmentChina Pharmacy201122103
  • ZhengNDuYQLinJMPharmaceutical care for clinical pharmacists with bronchial asthma and chronic obstructive pulmonary disease patientsChin J Clin Pharmacol201127121
  • WangBGuoDHLiuGYTianHPractice of clinical pharmacist in senile endocrine departmentChin J Drug App Monitor2008555
  • AlbertiKGZimmetPZDefinition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultationDiabet Med19981575395539686693
  • MoriskyDEGreenLWLevineDMConcurrent and predictive validity of a self-reported measure of medication adherenceMed Care198624167743945130
  • MillerNHCompliance with treatment regimens in chronic asymptomatic diseasesAm J Med19971022A43499217586
  • SchillingerDGrumbachKPietteJAssociation of health literacy with diabetes outcomesJAMA2002288447548212132978
  • CiechanowskiPSKatonWJRussoJEWalkerEAThe patient-provider relationship: attachment theory and adherence to treatment in diabetesAm J Psychiatry20011581293511136630
  • Obreli-NetoPRGuidoniCMde Oliveira BaldoniAEffect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patientsInt J Clin Pharm201133464264921544559
  • RheeMKSlocumWZiemerDCPatient adherence improves glycemic controlDiabetes Educ200531224025015797853
  • RozenfeldYHuntJSPlauschinatCWongKSOral antidiabetic medication adherence and glycemic control in managed careAm J Manag Care2008142717518269302
  • ChiuYWChangJMLinLIAdherence to a diabetic care plan provides better glycemic control in ambulatory patients with type 2 diabetesKaohsiung J Med Sci200925418419219502135
  • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) GroupLancet199835291318548659742977
  • KahnSEStevenMHaffnerSMADOPT Study GroupGlycemic durability of rosiglitazone, metformin, or glyburide monotherapyN Engl J Med2006355232427244317145742
  • BorgesAPGuidoniCMFerreiraLDde FreitasOPereiraLRThe pharmaceutical care of patients with type 2 diabetes mellitusPharm World Sci201032673073620734138
  • OdegardPSGooAHummelJWilliamsKLGraySLCaring for poorly controlled diabetes mellitus: a randomized pharmacist interventionAnn Pharmacother200539343344015701763
  • Nichols-EnglishGPoirierSOptimizing adherence to pharmaceutical care plansJ Am Pharm Assoc (Wash)200040447548510932456
  • LaaksoMBenefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK Prospective Diabetes StudyCirculation19999944614629927388